Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Bronte Capital Management Pty Ltd.

Q1 2026 · 13F-HR

Bronte Capital Management Pty Ltd.holdings as filed

Filed 2026-04-27 · accession 0001471085-26-000002

$1.01B
Reported value
54
Positions
2026-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
75886F107REGNREGENERON PHARMACEUTICALS$133.5M13.2%172,787CommonSOLE
02079K305GOOGLALPHABET INC$109.7M10.9%381,490CommonSOLE
45841N107IBKRINTERACTIVE BROKERS GROUP$86.0M8.51%1,281,731CommonSOLE
084670702BRK/BBERKSHIRE HATHAWAY INC DEL$74.3M7.36%155,063CommonSOLE
83601L105VISA INC-CLASS A SHARES$72.3M7.16%239,370CommonSOLE
023135106AMZNAMAZON COM INC$59.5M5.89%285,739CommonSOLE
718172109PMPHILIP MORRIS INTL INC$56.4M5.58%341,098CommonSOLE
75886F107REGNREGENERON PHARMACEUTICALS$53.0M5.24%68,600CALLSOLE
22052L104CTVACORTEVA INC$42.1M4.17%502,790CommonSOLE
14040H105COFCAPITAL ONE FINL CORP$34.2M3.38%187,369CommonSOLE
31946M103FCNCAFIRST CTZNS BANCSHARES INC N$31.1M3.08%16,492CommonSOLE
M8216R110VANECK ETF TRUST$19.1M1.89%208,088CommonSOLE
254687106DISDISNEY WALT CO$17.9M1.77%185,677CommonSOLE
G0896C103TBBBBBB FOODS INC$17.2M1.71%487,550CommonSOLE
640268306NKTRNEKTAR THERAPEUTICS$14.6M1.44%202,500CALLSOLE
640268306NKTRNEKTAR THERAPEUTICS$14.3M1.41%198,256CommonSOLE
G4412G101HLFHERBALIFE NUTRITION LTD$13.8M1.37%939,926CommonSOLE
384637104GHCGRAHAM HLDGS CO$13.5M1.34%12,785CommonSOLE
115637900BROWN FORMAN CORP$13.1M1.29%493,902CommonSOLE
02043Q107ALNYALNYLAM PHARMACEUTICALS INC$12.3M1.22%37,245CommonSOLE
83601L103SOTERA HEALTH CO$12.1M1.20%843,710CommonSOLE
464287648IWOISHARES TR$11.8M1.17%37,542CommonSOLE
464287556IBBISHARES TR$11.7M1.16%69,265CommonSOLE
833635105SQMSOCIEDAD QUIMICA Y MINERA DE$9.9M0.98%122,419CommonSOLE
051774107AURAURORA INNOVATION INC$9.6M0.95%2,318,748CommonSOLE
651639106NEMNEWMONT CORP$8.2M0.81%75,408CommonSOLE
72352L106PINSPINTEREST INC$7.9M0.78%430,950CommonSOLE
M5216V106GLBEGLOBAL E ONLINE LTD$6.6M0.65%213,102CommonSOLE
06849F108BBARRICK MNG CORP$6.5M0.64%158,741CommonSOLE
53815P108RAMPLIVERAMP HLDGS INC$5.9M0.59%223,215CommonSOLE
70438V106PCTYPAYLOCITY HLDG CORP$4.0M0.39%36,611CommonSOLE
90041L105TPBTURNING PT BRANDS INC$3.7M0.37%42,859CommonSOLE
609207105MDLZMONDELEZ INTL INC$3.2M0.32%55,974CommonSOLE
83601L104VANECK ETF TRUST$3.2M0.32%26,566CommonSOLE
79546E104SBHSALLY BEAUTY HLDGS INC$3.1M0.30%220,737CommonSOLE
070830104BBWIBATH & BODY WORKS INC$2.9M0.29%155,508CommonSOLE
115637100BF/ABROWN FORMAN CORP$2.7M0.27%100,354CommonSOLE
46990A102JRVRJAMES RIV GROUP HOLDINGS INC$2.1M0.21%338,961CommonSOLE
M8216R109RSKDRISKIFIED LTD$1.9M0.19%488,481CommonSOLE
653656108NICENICE LTD$1.9M0.19%17,091CommonSOLE
464287648IWOISHARES TR$1.4M0.14%4,400CALLSOLE
91347P105OLEDUNIVERSAL DISPLAY CORP$1.0M0.10%11,121CommonSOLE
92345Y106VRSKVERISK ANALYTICS INC$550,6550.05%2,902CommonSOLE
293594107ENVXENOVIX CORPORATION$59,8290.01%11,550CommonSOLE
014442107ALECALECTOR INC$41,4560.00%19,282CommonSOLE
19249H103CHRSCOHERUS ONCOLOGY INC$32,5870.00%19,282CommonSOLE
142038108CRBUCARIBOU BIOSCIENCES INC$29,6910.00%15,627CommonSOLE
31189P102FATEFATE THERAPEUTICS INC$27,4240.00%22,853CommonSOLE
12529R107CCCCC4 THERAPEUTICS INC$26,3870.00%10,033CommonSOLE
729139105PLRXPLIANT THERAPEUTICS INC$23,4520.00%18,613CommonSOLE
00534A102IVVDINVIVYD INC$14,3160.00%11,012CommonSOLE
59935V107MISTMILESTONE PHARMACEUTICALS IN$12,3930.00%10,414CommonSOLE
753018100RANIRANI THERAPEUTICS HLDGS INC$10,9250.00%14,868CommonSOLE
35168W103GUTSFRACTYL HEALTH INC$7,7390.00%16,905CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.